EUVIMEDEUVIMED entdecken
Crossref

Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer

Jeevitaa Kshersagar, Mrunal N Damle, Poonam Bedge, Rakhi Jagdale, Kishor Tardalkar, Dhanaji Jadhav, Swapnali Jagadale, Yashwant Toro, Rakesh Sharma, Meghnad G Joshi

Breast Disease · 06.01.2023 · 41 (1) · 471-480

DOI: 10.3233/bd-220023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Disease, erschienen am 06.01.2023. Verfasst von Jeevitaa Kshersagar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cells & Regenerative Medicine, D. Y. Patil Deemed to be University, D. Y. Patil Vidyanagar, Kasba Bawda, Kolhapur, Maharashtra, In…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: In this study, the profiling of the expression of major histocompatibility complex (MHC) class I-related chain A and B (MICA/B) in human breast cancer tumor tissue, saliva, and urine samples of breast cancer patients and control is carried out. MICA/B is ligand of NKG2D receptor expressed on malignant cells. The release of MICA/B from tumor tissue comprises an immune escape mechanism that impairs antitumor immunity. Based on this literature we explored the potential of soluble MICA (sMICA) as a marker in breast cancer (BC). METHODS: The expression was profiled by using immunohistochemistry (MICA/B), western blot (MICA/B) and ELISA (MICA). RESULTS: The optical density of western blot of MICA/B in different stages of BC illustrated significant difference as per one way analysis of variance and significant difference with stage III and IV by Dunnett’s multiple comparisons test respectively. Analysis of sMICA in serum, saliva and urine of BC patients revealed significantly higher levels (median 41.0 ± 4.1 pg/ml in pre-treatment sera, 181.9 ± 1.6 pg/ml in saliva and 90.7 ± 1.7 pg/ml in urine) than in control (median

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleDown-RegulationHistocompatibility Antigens Class INeoplasm StagingImmunohistochemistry

Stichwörter der Autor:innen

Breast cancerMICA/BsMICA/B

Substanzen

Histocompatibility Antigens Class I

Autor:innen und Institutionen

  • Department of Stem Cells & Regenerative Medicine, D. Y. Patil Deemed to be University, D. Y. Patil Vidyanagar, Kasba Bawda, Kolhapur, Maharashtra, India.
  • Stem Plus Biotech, SMK Commercial Complex, Near Shivaji Maharaj Putla, Gaon Bhag, Sangli, Maharashtra, India.
  • Department of Pathology, Shri Siddhivinayak Ganpati Cancer Hospital, Miraj, Sangli, Maharashtra, India.
  • Department of Statistics, Yashavantrao Chavan Institute of Science, Satara, Maharashtra, India.
  • Department of Scientific and Industrial Research Organization, Shri Siddhivinayak Ganpati Cancer Hospital, Miraj, Sangli, Maharashtra, India.
  • Department of Obstetrics and Gynaecology, Dr. D Y Patil Medical College, Hospital and Research Institute, Kadamwadi, Kolhapur, Maharashtra, India.

Zitieren

APA

Kshersagar, J., Damle, M. N., Bedge, P., Jagdale, R., Tardalkar, K., Jadhav, D., Jagadale, S., Toro, Y., Sharma, R., & Joshi, M. G. (2023). Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer. Breast Disease, 41(1), 471-480. https://doi.org/10.3233/bd-220023

Vancouver

Kshersagar J, Damle MN, Bedge P, Jagdale R, Tardalkar K, Jadhav D, et al. Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer. Breast Disease. 2023;41(1):471-480. doi:10.3233/bd-220023

BibTeX
@article{Kshersagar2023,
  author = {Kshersagar, Jeevitaa and Damle, Mrunal N and Bedge, Poonam and Jagdale, Rakhi and Tardalkar, Kishor and Jadhav, Dhanaji and Jagadale, Swapnali and Toro, Yashwant and Sharma, Rakesh and Joshi, Meghnad G},
  title = {Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer},
  journal = {Breast Disease},
  year = {2023},
  volume = {41},
  number = {1},
  pages = {471--480},
  doi = {10.3233/bd-220023}
}
Kostenlos starten →